Juvenile Diabetes Cure Alliance

Juvenile Diabetes Cure Alliance Announces 4th Annual T1D Cure 100 Mile Challenge

Retrieved on: 
Monday, October 9, 2023
Research, Men, Sports, General Health, Consumer, Parenting, Children, Science, Women, Health, Running, Diabetes, JDCA, Cure, Walking, Juvenile Diabetes Cure Alliance, T1D, Publication, Quality of life, Pharmaceutical industry

The Juvenile Diabetes Cure Alliance (JDCA), the leading nonprofit organization dedicated to research and advocacy toward finding a cure for type 1 diabetes, today proudly announced the 4th annual T1D Cure 100 Mile Challenge.

Key Points: 
  • The Juvenile Diabetes Cure Alliance (JDCA), the leading nonprofit organization dedicated to research and advocacy toward finding a cure for type 1 diabetes, today proudly announced the 4th annual T1D Cure 100 Mile Challenge.
  • This year’s event is scheduled to commence on November 1st, coinciding with the start of National Diabetes Month, and will run through December 8th.
  • “We’re very excited to launch this year’s Diabetes Month awareness and fundraising event for a T1D Cure, and we are confident that it will be the best yet,” says Phil Shaw, Executive Director of the Juvenile Diabetes Cure Alliance.
  • For more information on the Juvenile Diabetes Cure Alliance’s T1D 100 Mile Challenge, please visit www.thejdca.org , or follow along on Facebook and Twitter .

Creative Medical Technology Holdings Reports Positive Data on ImmCelz™ Immunotherapy Product

Retrieved on: 
Tuesday, October 12, 2021
Elective surgery, Company, Juvenile Diabetes Cure Alliance, Forward-looking statement, Autoimmunity, Immunotherapy, OTC Markets Group, Adult, OTC, Pacific Northwest Diabetes Research Institute, Cell, Cancer, Coronavirus Scientific Advisory Board (Turkey), Rheumatoid arthritis, Advanced Cell Therapeutics, Commission, China Biologic Products, FDA, Virus, News, U.S. Securities and Exchange Commission, University, Immune system, Neurology, Security (finance), Stroke, B cell, Kidney, CEO, Medicine, IND, Urology, Immunity, Pharmaceutical industry, Vaccine

PHOENIX, Oct. 12, 2021 /PRNewswire/ --(OTC-CELZ) Creative Medical Technology Holdings Inc. announced today proof of concept data demonstrating the ability of its next generation ImmCelz immunotherapy product to "reprogram" patient immune cells using the Company's patent pending "ex vivo cell-free" reprogramming protocol.

Key Points: 
  • PHOENIX, Oct. 12, 2021 /PRNewswire/ --(OTC-CELZ) Creative Medical Technology Holdings Inc. announced today proof of concept data demonstrating the ability of its next generation ImmCelz immunotherapy product to "reprogram" patient immune cells using the Company's patent pending "ex vivo cell-free" reprogramming protocol.
  • The ability to use cell-free reprogramming is a giant leap for using patient specific immune therapies.
  • Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in immunotherapy, neurology, urology and orthopedics and is currently listed on the OTC under the ticker symbol CELZ.
  • See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov .

2021 Sun Life Walk to Cure Diabetes for JDRF

Retrieved on: 
Thursday, June 3, 2021
JDRF, Juvenile Diabetes Cure Alliance

TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that rallies the type 1 diabetes (T1D) community to unite and raise funds for T1D research.

Key Points: 
  • TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that rallies the type 1 diabetes (T1D) community to unite and raise funds for T1D research.
  • The Sun Life Walk to Cure Diabetes for JDRF is a testament to the passion and resolve of a group of people who are inspired by a common goal: to create a world without T1D.
  • Sun Life has been involved with the Walk since 2014 as the National Sponsor and increased its already strong commitment to diabetes in Canada by becoming the National Title Sponsor of the Walk in 2018.
  • JDRF is the largest charitable funder of and advocate for research to cure, prevent and treat T1D in the world.

Virtual Event JDRF Illinois One Dream Gala - Close to Home Raises Over $8.5 Million for Type 1 Diabetes Research

Retrieved on: 
Tuesday, December 15, 2020
JDRF, Juvenile Diabetes Cure Alliance

This virtual event's funds will accelerate life-changing breakthroughs to cure, prevent, and treat type 1 diabetes (T1D) and its complications.

Key Points: 
  • This virtual event's funds will accelerate life-changing breakthroughs to cure, prevent, and treat type 1 diabetes (T1D) and its complications.
  • "The T1D community is unlike anything I've ever seen before" said Mimi K. Crabtree, Executive Director of JDRF Illinois.
  • "We showed that together, even while apart, we will turn type one into type none."
  • To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception.

JDRF Canada is marking National Diabetes Awareness Month by asking those impacted to write a letter to type 1 diabetes with the launch of their "Dear Type 1" Campaign

Retrieved on: 
Tuesday, November 10, 2020
JDRF, Organ systems, Health, Diabetes, Clinical medicine, Juvenile Diabetes Cure Alliance, Mark Atkinson

TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- JDRF Canada, the leading organization funding type 1 diabetes(T1D) research, is marking National Diabetes Awareness Month (NDAM) by honouring the power and resilience of the T1D community with the Dear Type 1 campaign.

Key Points: 
  • TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- JDRF Canada, the leading organization funding type 1 diabetes(T1D) research, is marking National Diabetes Awareness Month (NDAM) by honouring the power and resilience of the T1D community with the Dear Type 1 campaign.
  • As we continue to navigate the COVID-19 pandemic, we cannot let research and support for those living with type 1 diabetes slow down.
  • November is National Diabetes Awareness Month, which is celebrated across the world as a month to educate and raise awareness about the disease.
  • JDRF is the leading global organization funding type 1 diabetes (T1D) research.

JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community

Retrieved on: 
Wednesday, July 8, 2020
Technology, Mobile, Wireless, Medical devices, Diabetes, Philanthropy, Software, Internet, Health, Foundation, JDRF, Diabetes, The Diabetes Educator, Tandem Diabetes Care, Medicine, Health, Clinical medicine, Juvenile Diabetes Cure Alliance, JDRF, Tandem Diabetes Care, Inc.

The JDRF and Tandem partnership aims to actively support the growing needs of the T1D community and help address the gap in diabetes education on these topics through regional and local activities, including select Type One Nation Summits and JDRF One Walk events.

Key Points: 
  • The JDRF and Tandem partnership aims to actively support the growing needs of the T1D community and help address the gap in diabetes education on these topics through regional and local activities, including select Type One Nation Summits and JDRF One Walk events.
  • Education is the foundation for improved quality of life and clinical outcomes for people with type 1 diabetes, and we are proud to partner with JDRF in furthering our shared mission to support the diabetes community, said Brian Hansen, Executive Vice President and Chief Commercial Officer at Tandem Diabetes Care.
  • Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.
  • Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.

JDRF Reaches New Milestones in Work to Drive Cures for Type 1 Diabetes and Improve Lives

Retrieved on: 
Friday, February 14, 2020
Organ systems, RTT, Endocrine system, Medicine, JDRF, Beta cell, Type 1 diabetes, Diabetes, The Environmental Determinants of Diabetes in the Young, Juvenile Diabetes Cure Alliance

The organization also supported new investment through the JDRF T1D Fund in 15 T1D companies, including 11 focused on cures.

Key Points: 
  • The organization also supported new investment through the JDRF T1D Fund in 15 T1D companies, including 11 focused on cures.
  • "We are focused on beta cell therapies and immune therapies to deliver cures for T1D," Kowalski said.
  • "At the same time, we continue accelerating work in glucose control and complication therapies to improve the lives of those living with type 1 diabetes today."
  • "JDRF works to build partnerships that advance research and build and sustain critical support for type 1 diabetes (T1D) research funded by the Federal Government."

JDRF Recognizes NFL Superstars Who Help Drive Type 1 Diabetes Awareness Through The #MyCauseMyCleats Campaign

Retrieved on: 
Tuesday, December 10, 2019
JDRF, Juvenile Diabetes Cure Alliance

NEW YORK, Dec. 10, 2019 /PRNewswire/ --JDRF, the leading global organization funding type 1 diabetes (T1D) research, thanks NFL SuperstarsMark Andrewsand Orlando BrownJr.

Key Points: 
  • NEW YORK, Dec. 10, 2019 /PRNewswire/ --JDRF, the leading global organization funding type 1 diabetes (T1D) research, thanks NFL SuperstarsMark Andrewsand Orlando BrownJr.
  • Throughout the campaign, players have represented hundreds of charitable organizations that focus on causes such as youth development, health and wellness, and military and veteran support, among others.
  • In support of the players, the NFL shares videos and profiles players throughout December, highlighting the stories behind their cleats.
  • JDRF is the leading global organization funding type 1 diabetes (T1D) research.

Thousands of cyclists come together to find a cure for type 1 diabetes at Yonge-Dundas Square

Retrieved on: 
Wednesday, October 9, 2019
JDRF, Diabetes, Health, Medicine, Clinical medicine, Juvenile Diabetes Cure Alliance, Mark Atkinson

JDRF is the leading global organization funding type 1 diabetes research.

Key Points: 
  • JDRF is the leading global organization funding type 1 diabetes research.
  • Our goal is to raise funds to support the most advanced international type 1 diabetes research and progressively remove the impact of this disease from peoples lives until we achieve a world without type 1 diabetes.
  • JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure type 1 diabetes.
  • JDRF is the largest charitable funder of and advocate for research to cure, prevent and treat T1D in the world.

JDRF and Beyond Type 1 Launch Alliance to Serve Type 1 Diabetes (T1D) Community

Retrieved on: 
Tuesday, September 24, 2019
JDRF, Juvenile Diabetes Cure Alliance

The JDRF - Beyond Type 1 Alliance combines the power of JDRF , the leading global organization funding T1D research, and Beyond Type 1 , the organization with the largest online community of any diabetes nonprofit.

Key Points: 
  • The JDRF - Beyond Type 1 Alliance combines the power of JDRF , the leading global organization funding T1D research, and Beyond Type 1 , the organization with the largest online community of any diabetes nonprofit.
  • Together, JDRF and Beyond Type 1 will promote Alliance community programs, such as events and peer support, to offer more opportunities to the T1D community.
  • "Beyond Type 1 is doing exceptional work for the T1D community," said Aaron J. Kowalski, Ph.D., JDRF President and CEO.
  • "JDRF and Beyond Type 1 both work tirelessly to serve the T1D community, and each brings complementary strengths to this partnership.